142 related articles for article (PubMed ID: 37823255)
1. Clinical characteristics and prognosis of patients with isolated cardiac sarcoidosis: Insights from the ILLUMINATE-CS study.
Maeda D; Matsue Y; Dotare T; Sunayama T; Iso T; Yoshioka K; Nabeta T; Naruse Y; Kitai T; Taniguchi T; Tanaka H; Okumura T; Baba Y; Minamino T
Eur J Heart Fail; 2024 Jan; 26(1):77-86. PubMed ID: 37823255
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in clinical characteristics and prognosis of patients with cardiac sarcoidosis.
Iso T; Maeda D; Matsue Y; Dotare T; Sunayama T; Yoshioka K; Nabeta T; Naruse Y; Kitai T; Taniguchi T; Tanaka H; Okumura T; Baba Y; Minamino T
Heart; 2023 Aug; 109(18):1387-1393. PubMed ID: 37185298
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Value of B-Type Natriuretic Peptide in Patients With Cardiac Sarcoidosis Without Heart Failure: Insights From ILLUMINATE-CS.
Miyakuni S; Maeda D; Matsue Y; Yoshioka K; Dotare T; Sunayama T; Nabeta T; Naruse Y; Kitai T; Taniguchi T; Tanaka H; Okumura T; Baba Y; Matsumura A; Minamino T
J Am Heart Assoc; 2022 Dec; 11(24):e025803. PubMed ID: 36515231
[TBL] [Abstract][Full Text] [Related]
4. Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry.
Nabeta T; Kitai T; Naruse Y; Taniguchi T; Yoshioka K; Tanaka H; Okumura T; Sato S; Baba Y; Kida K; Tamaki Y; Matsumoto S; Matsue Y
Eur Heart J; 2022 Sep; 43(36):3450-3459. PubMed ID: 35781334
[TBL] [Abstract][Full Text] [Related]
5. Predictors of outcome in a contemporary cardiac sarcoidosis population: Role of brain natriuretic peptide, left ventricular function and myocardial inflammation.
Kouranos V; Khattar RS; Okafor J; Ahmed R; Azzu A; Baksi JA; Wechalekar K; Cowie MR; Wells AU; Lüscher TF; Sharma R
Eur J Heart Fail; 2023 Dec; 25(12):2287-2298. PubMed ID: 37877328
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of patients with isolated cardiac sarcoidosis confirmed by clinical diagnostic criteria.
Takaya Y; Nakamura K; Nishii N; Ito H
Int J Cardiol; 2021 Dec; 345():49-53. PubMed ID: 34743890
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.
Tezuka D; Terashima M; Kato Y; Toriihara A; Hirasawa K; Sasaoka T; Yoshikawa S; Maejima Y; Ashikaga T; Suzuki J; Hirao K; Isobe M
J Card Fail; 2015 Apr; 21(4):313-22. PubMed ID: 25512195
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of isolated cardiac sarcoidosis based on new guidelines.
Kawai H; Sarai M; Kato Y; Naruse H; Watanabe A; Matsuyama T; Takahashi H; Motoyama S; Ishii J; Morimoto SI; Toyama H; Ozaki Y
ESC Heart Fail; 2020 Oct; 7(5):2662-2671. PubMed ID: 32578957
[TBL] [Abstract][Full Text] [Related]
9. Relationship of Mild to Moderate Impairment of Left Ventricular Ejection Fraction With Fatal Ventricular Arrhythmic Events in Cardiac Sarcoidosis.
Akama Y; Fujimoto Y; Matsue Y; Maeda D; Yoshioka K; Dotare T; Sunayama T; Nabeta T; Naruse Y; Kitai T; Taniguchi T; Sato S; Tanaka H; Okumura T; Baba Y; Minamino T
J Am Heart Assoc; 2024 Mar; 13(6):e032047. PubMed ID: 38456399
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Outcomes of Cardiac Sarcoid: Prognostic Implications of Isolated Cardiac Involvement and Impact of Diagnostic Delays.
Sink J; Joyce C; Liebo MJ; Wilber DJ
J Am Heart Assoc; 2023 Oct; 12(19):e028342. PubMed ID: 37750587
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and prognosis of isolated cardiac sarcoidosis diagnosed using new guidelines with dedicated FDG PET/CT.
Okada T; Kawaguchi N; Miyagawa M; Matsuoka M; Tashiro R; Tanabe Y; Kido T; Miyoshi T; Higashi H; Inoue T; Okayama H; Yamaguchi O; Kido T
J Nucl Cardiol; 2023 Feb; 30(1):280-289. PubMed ID: 35804283
[TBL] [Abstract][Full Text] [Related]
12. Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis.
Joyce E; Ninaber MK; Katsanos S; Debonnaire P; Kamperidis V; Bax JJ; Taube C; Delgado V; Ajmone Marsan N
Eur J Heart Fail; 2015 Jan; 17(1):51-62. PubMed ID: 25431267
[TBL] [Abstract][Full Text] [Related]
13. Right Ventricular Abnormalities on Cardiovascular Magnetic Resonance Imaging in Patients With Sarcoidosis.
Velangi PS; Chen KA; Kazmirczak F; Okasha O; von Wald L; Roukoz H; Farzaneh-Far A; Markowitz J; Nijjar PS; Bhargava M; Perlman D; Akçakaya M; Shenoy C
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1395-1405. PubMed ID: 31954639
[TBL] [Abstract][Full Text] [Related]
14. Comparisons between biopsy-proven versus clinically diagnosed cardiac sarcoidosis.
Kitai T; Nabeta T; Naruse Y; Taniguchi T; Yoshioka K; Miyakoshi C; Kurashima S; Miyoshi Y; Tanaka H; Okumura T; Baba Y; Furukawa Y; Matsue Y; Izumi C
Heart; 2022 Nov; 108(23):1887-1894. PubMed ID: 35790370
[TBL] [Abstract][Full Text] [Related]
15. Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres.
Fussner LA; Karlstedt E; Hodge DO; Fine NM; Kalra S; Carmona EM; Utz JP; Isaac DL; Cooper LT
Eur J Heart Fail; 2018 Dec; 20(12):1713-1720. PubMed ID: 30378224
[TBL] [Abstract][Full Text] [Related]
16. Utility of Updated Japanese Circulation Society Guidelines to Diagnose Isolated Cardiac Sarcoidosis.
Sato K; Kawamatsu N; Yamamoto M; Machino-Ohtsuka T; Ishizu T; Ieda M
J Am Heart Assoc; 2022 Jul; 11(13):e025565. PubMed ID: 35766294
[TBL] [Abstract][Full Text] [Related]
17. Cardiac sarcoidosis outcome differences: A comparison of patients with de novo cardiac versus known extracardiac sarcoidosis at presentation.
Rosen NS; Pavlovic N; Duvall C; Wand AL; Griffin JM; Okada DR; Chrispin J; Tandri H; Mathai SC; Stern B; Pardo CA; Kasper EK; Sharp M; Chen ES; Gilotra NA
Respir Med; 2022 Jul; 198():106864. PubMed ID: 35550245
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Prognostic Significance of Ventricular Repolarization Dispersion in Patients with Cardiac Sarcoidosis.
Kobayashi Y; Nagai T; Takenaka S; Kato Y; Komoriyama H; Nagano N; Kamiya K; Konishi T; Sato T; Omote K; Tsujinaga S; Iwano H; Kusano K; Yasuda S; Ogawa H; Ishibashi-Ueda H; Anzai T
Am J Cardiol; 2021 Aug; 152():125-131. PubMed ID: 34127248
[TBL] [Abstract][Full Text] [Related]
19. Risk of Adverse Cardiovascular Events in Cardiac Sarcoidosis Independent of Left Ventricular Function.
Rosenthal DG; Cheng RK; Petek BJ; Masri SC; Mikacenic C; Raghu G; Patton KK
Am J Cardiol; 2020 Jul; 127():142-148. PubMed ID: 32402485
[TBL] [Abstract][Full Text] [Related]
20. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults.
Kandolin R; Lehtonen J; Kupari M
Circ Arrhythm Electrophysiol; 2011 Jun; 4(3):303-9. PubMed ID: 21427276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
